垂体后叶素治疗肺结核咯血临床研究

Clinical Analysis of Vasopressin Treatment of Tuberculosis Hemoptysis

目的：探究肺结核咯血患者采用垂体后叶素治疗的效果。方法选取2013年8月～2014年9月收治的37例肺结核咯血患者进行治疗，随机分组，实验组患者20例采用垂体后叶素和酚妥拉明的治疗，对照组17例患者选择酚妥拉明的治疗，对比患者的治疗效果和不良反应。结果实验组患者不良反应率为5.0%，治疗有效率为95.0%；对照组患者不良反应发生率为23.5%，治疗有效率为82.35%。两组患者的治疗效果和不良反应率差异有统计学意义（P〈0.05）。结论肺结核咯血患者在治疗中选择垂体后叶素和酚妥拉明的综合治疗，可缓解症状，减少咯血时间，快速止血，副作用少，效果显著。

Objective To explore vasopressin treatment effect to patients of tuberculosis hemoptysis. Methods We chose 37 patients of tuberculosis hemoptysis who were treated in hospital from August 2013 to September 2014 and separate them into groups at random,twenty patients in study group were given vasopressin combined with phentolamine treatment,while 17 patients in control group were given phentolamine treatment only,and then compared treatment effects as wel as side-effect incidence between two groups. Results Side-effect incidence in study group was 5.0% and treatment efficacy in study group was up to 95.0%,while,the side-effect incidence and treatment efficacy in control group were 23.5% and 82.35%,respectively, there was a treatment differential between two groups,and such a differential had statistic value（P〈0.05）. Conclusion Vasopressin combined with phentolamine treatment is of efficacy in treatment of patients with tuberculosis hemoptysis,it is conducive to relieving patients’symptoms and decreasing their hemoptysis time and stop bleeding quickly with high efficiency and few side effects.